The FDA Announces Two More Antacid Recalls Due to Cancer Risk
by Michele Cohen Marill from on (#4XQXG)
Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.